ADVANCED CELL & GENE THERAPY LLC
ADVANCED CELL & GENE THERAPY LLC is a federal contractor, registered under UEI WL5TMYA1RLD7 and CAGE code 7MEC3. It has been awarded $12,900 in federal contracts. Primary work spans Other Scientific and Technical Consulting Services. Top awarding agencies include Department Of Health And Human Services.
Contact Information
Registration and classification details
Registration
UEI Code
WL5TMYA1RLD7CAGE Code
7MEC3Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
ADVANCED CELL & GENE THERAPY LLC specializes in advanced biotechnological research and development focused on cell and gene therapy platforms, leveraging cutting-edge molecular biology, vector engineering, and translational science to support preclinical and clinical-stage therapeutic innovation. Th...
ADVANCED CELL & GENE THERAPY LLC specializes in advanced biotechnological research and development focused on cell and gene therapy platforms, leveraging cutting-edge molecular biology, vector engineering, and translational science to support preclinical and clinical-stage therapeutic innovation. The company’s core capabilities include viral vector design and manufacturing, ex vivo cell engineering, gene editing workflows using CRISPR and base-editing technologies, and process development for GMP-compliant cell therapy production. Their technical expertise extends to analytical characterization of therapeutic candidates, including flow cytometry, qPCR, NGS, and potency assays, with a focus on scalability and regulatory readiness for FDA submission. A key differentiator is their integrated approach to bridging academic discovery with industrial-scale application, emphasizing process robustness and patient-specific therapeutic optimization. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal collaboration can be inferred. The absence of recent award data precludes identification of primary federal partners or programmatic focus areas. The company operates under NAICS 541690, which encompasses other scientific and technical consulting services, indicating a service-based model centered on R&D support rather than product commercialization. In practice, this suggests they provide specialized contract research services to government-funded biomedical programs, academic institutions, or biopharma collaborators engaged in regenerative medicine and personalized therapeutics. ADVANCED CELL & GENE THERAPY LLC is a small business structured as a 2L entity, headquartered in Chapel Hill, North Carolina, a region known for its concentration of biotech research and academic medical centers. The company holds no government certifications, positioning it as a nimble, privately operated research services provider focused on innovation in advanced therapy modalities. Its geographic presence aligns with the Triangle’s life sciences ecosystem, facilitating collaboration with NIH-funded labs and clinical trial networks.
Key performance metrics
Award counts and award dollars by type, as prime and as subcontractor.
Awards Count
1
All time
Active
0
Currently performing
Completed
1
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award analytics
Awards by agency, industry, year, award type, size, and place of performance.
Compete with ADVANCED CELL & GENE THERAPY LLC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for ADVANCED CELL & GENE THERAPY LLC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
